Overview of FBCx Research, Safety, and Effectiveness
FBCx Clinical Trial (Click Link)
Summary
Published Clinical Data
Clinical trial data on obese type II diabetics published in the January 2007 issue of the tier one peer-reviewed journal, Diabetes/Metabolism Research and Reviews, changes the face of dietary management in obese patients with type II diabetes.
The impressive highlights of this trial include:
- Significant (adjusted) weight loss among all participants in the active group
- Decreases in serum triglyceride levels of up to 20% within two months
- Decreases in blood LDL cholesterol of up to 15-25% within six months
- Reduction of serum cholesterol of up to 20% within six months
Subjects in pre-clinical trials, including non-diabetic patients, showed dramatic consistent weight loss with significant decreases in their blood cholesterol and triglyceride levels. Many consumers reported significant weight loss within the first few weeks and over 60 pounds of total weight loss, without changes to their lifestyle or diet.*
*Results may vary